No Data
No Data
Express News | LakeShore Biopharma Shares Are Trading Higher After the Company Announced Preliminary H1 2025 Financial Results and Guidance
LakeShore Biopharma Still Sees FY25 Revenue up in Double Digits Year-over-year
Express News | LakeShore Biopharma Sees Prelim. 1H Revenue RMB350M-RMB380M, Representing 28-39% Growth
LakeShore Biopharma To Carry Out 1-for-10 Reverse Stock Split On October 4th, 2024
Express News | Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
12 Health Care Stocks Moving In Friday's Pre-Market Session
No Data
No Data